³Ô¹ÏÍøÕ¾

Latest pancreatic cancer News

Amplia enters into preclinical collaboration with Korean drug screening company
New International Research Laboratory will tackle treatment-resistant cancer
Discovery reveals how ovarian cancer disables immune cells
How melanoma cells escape oxidative stress to metastasize
Jreissati Pancreatic Centre In Global Cancer Trial
$55 Million To Scale Up Aussie Innovations
Box Rallies reaches $50 million fundraising milestone for Cancer Council partnership, fuelling groundbreaking cancer research across Australia
Researchers gain insights into KRAS mutations in pancreatic cancers
Distinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer Therapeutics
Walking For Pancreatic Cancer Research
Workers’ Compensation and Rehabilitation and Other Legislation Amendment Act 2024
Amplia says five patients recording sustained reduction in tumour size in trial
Noxopharm announces CRO-67 results in complex pancreatic cancer studies
Circular RNAs – New Frontier In Cancer Research
Registry set to improve access to cancer therapy
Survivor Joins Cancer Campaign
Weight-loss jabs linked to lower cancer risk compared with insulin – new study
Amplia anounces completion of recruitment of first 26 patients in Phase 2 trial
PhD Top Up Scholarship supports research into pancreatic cancer
Risky Drinking Even Riskier For Women
Fifth patient is treated with the OncoSil device in PANCOSIL trial
EnGeneIC and Singapore Institute of Advanced Medicine Holdings Forge Strategic Partnership to Revolutionise Cancer Treatment in Asia
Margaret’s How Mother’s Struggle Transformed Lives
Pancreatic cancer research receives $8m philanthropic funding boost
Cancer is increasingly survivable – but it shouldn’t depend on your ability to ‘wrangle’ the health system
Binge drinking is a growing public health crisis − a neurobiologist explains how research on alcohol use disorder has shifted
Wish Granted Just In Time For Proud Nan
‘My Mum Was Everything To Me’
Cancer: here’s the role exercise plays, from prevention to treatment
Robin is hosting a morning tea in honour of three of her closest family members who she has lost to cancer
Personalised mRNA vaccines: a revolutionary new approach in melanoma treatment
Tour de Cure backs further development of Noxopharm’s preclinical brain cancer candidate
First Turkish patient treated with OncoSil cancer treatment device
Cancer Research KI network support translational collaboration in molecular mechanisms at Schulte lab
Tour de Cure grant for brain cancer research
Cancer often requires more than one treatment − an oncologist explains why some patients like Kate Middleton receive both chemotherapy and surgery
She is awarded the Sjöberg Prize for laying the foundations of a cancer vaccine
Can4Cancer pedals towards $20 million raised for cancer research
Pancreatic Cancer Rising In Younger People
New data shows top five cancers projected to affect people in Nepean Blue Mountains Local Health District
Raising our voices for better palliative care
UNSW researchers receive more than $20m in Ideas and Development Grants
FDA grants fast-track designation for EnGeneIC’s pancreatic cancer candidate
EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic
OncoSil Medical onboards first patient in the PANCOSIL clinical trial
Korean regulator approves Amplia Therapeutics’ pancreatic cancer trial
Dr Ben Wylie research to develop kinder and less toxic treatments for cancer
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options